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Thedevelopmentofcognitiveenhancersfromplantspossessingantioxidantshasgainedmuchattentionduetotheroleofoxidative
stress-induced cognitive impairment. Thus, this study aimed to determine the eﬀect of ginger extract, or Zingiber oﬃcinale,o nt h e
cognitive function of middle-aged, healthy women. Sixty participants were randomly assigned to receive a placebo or standardized
plant extract at doses of 400 and 800mg once daily for 2 months. They were evaluated for working memory and cognitive function
using computerized battery tests and the auditory oddball paradigm of event-related potentials at three diﬀerent time periods:
beforereceivingtheintervention,onemonth,andtwomonths.Wefoundthattheginger-treatedgroupshadsigniﬁcantlydecreased
P300 latencies, increased N100 and P300 amplitudes, and exhibited enhanced working memory. Therefore, ginger is a potential
cognitive enhancer for middle-aged women.
1.Introduction
Recent ﬁndings suggest that middle-aged women usually
develop some form of cognitive impairment. It was found
that middle-aged women performed poorly in various areas
of cognitive function including attention, calculation and
immediate recall (assessed using Minimental state examina-
tion (MMSE)) [1]. Evidence has also shown that oxidative
stress contributes to cognitive impairment as age advanced
[2]. Due to the increase in the middle-aged population,
an abundance of research has focused on the development
of cognitive enhancers from medicinal plants reputed for
antioxidant and cognitive enhancing eﬀects. Ginger, or
Zingiber oﬃcinale, a plant in the family of Zingiberaceae,
has longterm been used as both a spice and as a medicine
in Asian, Indian, and Arabian folklore. The rhizomes of
Zingiber oﬃcinale exhibit a wide range of pharmacological
properties including antilipidemia [3], antiemetic [4], anti-
inﬂammation, and antiarthritis [5]. According to Arabian
folklore, ginger has been claimed to improve memory.
Moreover, it has also been traditionally used as an ingredient
for cognitive enhancement. Our preliminary data in Wistar
rats showed that ginger rhizomes extract could enhance
memory and protect against brain damage [6]. In addition,
it was also reported to have antioxidant eﬀects [7, 8].
Based on the antioxidant and cognitive enhancing eﬀects of
ginger rhizomes extract, the present neuropsychological and
electrophysiological study aims to determine the eﬀect of
ginger rhizomes extract on the cognitive function of middle-
aged women.2 Evidence-Based Complementary and Alternative Medicine
2.MaterialsandMethods
2.1. Participants. Sixty healthy, Thai, middle-aged women
(mean age 53.40 ± 3.57 years) were recruited to partic-
ipate in the present study, which was approved by the
Ethical Committee of the Faculty of Medicine at Khon
Kaen University. Prior to investigation, each volunteer pro-
vided informed consent and completed the medical health
questionnaire. Participants were also screened for physical
health by a physician in order to assure healthy condition.
Inclusion criteria were healthy, middle-aged, Thai National
women between the ages of 50 and 60 residing in the
Northeast Region of Thailand. Exclusion criteria included
any history of cardiovascular disease, respiratory disease,
neuropsychological disease, head injury, diabetes, cancer,
alcohol addiction, and anyone who smoked more than 10
cigarettes per day because all mentioned conditions could
produce the disturbance of cognitive function. Individuals
taking prescribed, nonprescribed drugs, or nutraceutical
compounds known to inﬂuence the function of the nervous
system were excluded. Participants were randomly divided
into 3 separate groups: placebo, Zingiber oﬃcinale 400mg,
and Zingiber oﬃcinale 800mg.
2.2. The Preparation of the Standardized Extract of Zingiber
oﬃcinale. A standardized extract of Zingiber oﬃcinale was
prepared by the Thailand Institute of Scientiﬁc and Tech-
nologicalResearchinPathumSthani,Thailand.Standardiza-
tion and conformity of the extract were assured by strict in-
processcontrolsduringmanufactureandcompleteanalytical
control of the resulting dry extract. In brief, the dried
ginger rhizome powder was extracted with 95% ethanol
in a stainless steel tank for 5 to 10 days. The ﬁltrate was
evaporated to dryness under a vacuum at 35◦Co nar o t a r y
evaporator. The production yield of the extract was 6.84%
w/w. The phenolic compound of standardized ginger extract
contained 7.33% w/w of 6-gingerol and 1.34% w/w of 6-
shogaol.
2.3. Procedures and Treatments. This study was 2 months
in duration and was double blind, placebo controlled, and
arranged with randomized trials. A random list of numbers
was computer-generated. After being randomly assigned to
treatment groups, each participant received one capsule
of either the placebo or ginger extract (400 or 800mg)
once daily. The selected doses of Z. oﬃcinale are based
on the dosage range that produces cognitive enhancing
eﬀect in animal model and the safety range. The placebo
and ginger capsules had the same color, texture, size, and
odor. All participants were screened for baseline intellectual
function using standard progressive matrices (SPMs) in
order to avoid confounding error induced by the intellectual
function problem. Participants were assessed for cognitive
performanceafter1and2monthsoftreatment.Accordingto
the evaluation, all experimenters and staﬀ were instructed to
followastrictprotocolandweretoldnottodiscussanyissues
related to the use of medication. The medication compliance
was monitored by interview and counting the remaining
medication, and the side eﬀect was assessed via interview,
self-report, and physical exam in each visit. Subjects were
requested to call the study center if they experienced any
medical problems during the 60 days of study duration. At
the end of the study, they were also asked about any adverse
experiences.
2.4. Event-Related Potentials (ERPs)
2.4.1. ERP Recording. All subjects were assessed for cognitive
performance using the classic “oddball paradigm” of audi-
tory event-related potentials (N100 and P300 amplitudes
and latencies) [9]. The electroencephalogram (EEG) was
recorded via Cz, and linked mastoids were used as reference
for the electrode. The resistance of the electrodes was kept
below 5kohm. The analog ﬁlter band pass was 1–100Hz
[10]. For each stimulus, an epoch of 500ms duration
including a 100ms prestimulus period was extracted from
the continuous EEG. Epochs with a voltage change below
0.1µVo ra b o v e7 0µV were rejected from further analysis.
2.4.2. ERP Measurement. T h es u b j e c t sl i s t e n e dt oat r a i n
of tone bursts presented binaurally through headphones.
The standard stimuli had a tonal frequency of 650Hz
(60dB, 200ms) and occurred with a tonal frequency of
80%. The target stimuli had a tonal frequency of 1kHz
(60dB, 200ms) and occurred with a probability of 20%. All
participants were informed to pay attention and mentally
count infrequent target tones. Interstimulus intervals varied
randomly between 1250 and 3000ms. The N100 latency
range was determined to be 65–135ms, and the P300 latency
range was determined to be 280–375ms. Both the latency
and maximum amplitudes were measured for N100 and
P300 deﬂections. Any peaks outside of this range were
measured manually, and all peaks were visually examined
prior to measurement.
2.5. Computerized Assessment Battery Test. The computer-
ized assessment battery test was modiﬁed from the CDR
computerized assessment battery test used in hundreds
of European and North American drug trials which have
been previously reported to be sensitive to acute cognitive
improvements as well as impairments with a wide variety of
substances [11, 12]. Presentation was performed using note-
bookcomputerswithahigh-resolutionVGAcolourmonitor,
and, with the exception of written word recall tests, all
responses were recorded via a two-button (yes/no) response
box. The entire selection of tasks took approximately 20min.
Tests were administered in the following order: word pre-
sentation, picture presentation, simple reaction time, digit
vigilancetask,choicereactiontime,spatialworkingmemory,
numeric working memory, delayed word recognition, and
delayed picture recognition.
Word Presentation. Fifteen words, matched for frequency
andconcreteness,werepresentedinsequenceonthemonitor
for the participant to remember. The stimulus duration was
1s, as was the interstimulus interval.Evidence-Based Complementary and Alternative Medicine 3
Picture Presentation. A series of 20 photographic images was
presented on the monitor at the rate of 1 every 3s, with a
stimulus duration of 1s, for the participant to remember.
Simple Reaction Time. The participant was instructed to
press the “yes” response button as quickly as possible every
time the word “yes” was presented on the monitor. Fifty
stimuli were presented with an interstimulus interval that
varied randomly between 1 and 3.5s. Reaction times were
recorded in milliseconds.
Digit Vigilance Task. A target digit was randomly selected
and constantly displayed to the right of the monitor screen.
A series of digits was presented in the centre of the screen at
the rate of 80/min, and the participant was required to press
the “yes” button as quickly as possible every time the digit in
the series matched the target digit. The task lasted 1min and
there were 15 stimulus-target matches. Task measures were
accuracy (%), reaction time (milliseconds), and false alarms.
Choice Reaction Time. Either the word “no” or the word
“yes” was presented on the monitor, and the participant was
required to press the corresponding button as quickly as
possible. There were 50 trials of which the stimulus word was
chosen randomly with equal probability, with a randomly
varying interstimulus interval between 1 and 3.5s. Reaction
times (millisecond) and accuracy (%) were recorded.
Spatial Working Memory. A pictorial representation of a
house was presented on the screen with four of its nine
windows lit. The participant was instructed to memorize the
position of the illuminated windows. In 36 subsequent pre-
sentations of the house, one of the windows was illuminated,
and the participant decided whether or not this matched
one of the lighted windows in the original presentation. The
participant made their response by pressing the “yes” or
“no” response button as quickly as possible. Mean reaction
times were measured in milliseconds, and the accuracy of
responses to both original and novel (distractor) stimuli was
recorded as percentages used to derive a “percentage greater
than chance performance” score.
Numeric Working Memory. Five digits were presented se-
quentially for the participant to hold in memory. This was
followed by a series of 30 probe digits for each of which
the participant decided whether or not it had been in the
original series and pressed the “yes” or “no” response button
as appropriate and as quickly as possible. This was repeated
two further times with diﬀerent stimuli and probe digits.
Mean reaction times were measured in milliseconds, and the
accuracy of responses to both original and novel (distractor)
stimuli was recorded as percentages that were used to derive
a “percentage greater than chance performance” score.
Delayed Word Recognition. The original words and 15 dis-
tractor words were presented one at a time in randomized
order. For each word, the participant indicated whether
or not she recognized it as being included in the original
Table 1: Demographic data of subjects (n = 20/group).
Baseline data Placebo 400mg 800mg
Age (years) 53.92 ±3.82 54.33 ±4.12 54.33 ±3.17
Education (years) 5.50 ±3.70 5.40 ±3.68 5.15 ±2.74
Full scale IQ 98.95 ±4.42 99.75 ± 4.23 98.85 ±6.01
Blood sugar 90.06 ±8.45 89.10±13.08 91.15±10.16
Body mass index 21.95 ±1.90 22.78 ± 2.06 23.12 ±1.83
Blood pressure
systolic (mmHg) 121.00±7.72 117.70 ± 8.49 117.85±9.76
Blood pressure
diastolic (mmHg) 82.25 ±2.53 82.80 ± 2.73 80.50 ±3.73
Menstrual cessation
(years) 3.95 ±1.60 3.75 ±1.48 4.05 ±1.57
Data were presented as mean ± SD. P and F values were compared between
groups.
list of words by pressing the “yes” or “no” button as ap-
propriate and as quickly as possible. Mean reaction times
weremeasuredinmilliseconds,andtheaccuracyofresponses
to both original and novel (distractor) stimuli was recorded
as percentages that were used to derive a “percentage greater
than chance performance” score.
Delayed Picture Recognition. The original pictures and 20
distractor pictures were presented one at a time in a ran-
domized order. For each picture, participants indicated
whether or not it was recognized as being from the original
seriesbypressingthe“yes”or“no”buttonasappropriateand
as quickly as possible. Mean reaction times were measured in
milliseconds, and the accuracy of responses to both original
and novel (distractor) stimuli recorded as percentages that
were used to derive a “percentage greater than chance
performance” score.
To avoid learning eﬀect on computerized battery test, the
participants were assessed for working memory with diﬀer-
ent sets of parallel tests at the same diﬃculty level.
2.6. Statistical Analysis. Comparisons between doses were
made using analysis of variance (ANOVA) and followed the
r e c o m m e n d a t i o n so fK e p p e l[ 13], with planned comparison
being made between the placebo and each of the two
active treatments utilizing t-tests. Statistical signiﬁcance was
regarded at P value <0.05. In order to reject null hypothesis,
thesamplesizejustiﬁcationandpoweranalysisisconsidered.
Since the study is the preliminary study of clinical trial
phase zero, the study is performed in accordance with the
United States Food and Drug Administration’s (FDA) 2006
Guidance on Exploratory Investigational New Drug (IND)
Studies which suggests that the number of the sample size
can be a small number approximately 10–15 per group.
3. Results
3.1. Demographic Data of Subjects. The baseline demo-
graphic data for all participants is presented in Table 1.
There were no signiﬁcant diﬀerences found in demographic4 Evidence-Based Complementary and Alternative Medicine
12
8
4
0
−4
−8
−12
−100 0 100 200 300 400 500
(ms)
(
µ
V
)
Placebo
400mg
800mg
(a)
12
8
4
0
−4
−8
−12
−100 0 100 200 300 400 500
(ms)
(
µ
V
)
Placebo
400mg
800mg
(b)
12
8
4
0
−4
−8
−12
−100 0 100 200 300 400 500
(ms)
(
µ
V
)
Placebo
400mg
800mg
(c)
Figure 1: Average waveforms of the auditory event-related-potential at electrode Cz at various periods of treatment; (a) predose baseline,
(b) 1st month after substance administration, and (c) 2nd month after substance administration.
parameters. Therefore, all subjects successfully met inclusion
criteria and did not diﬀer signiﬁcantly.
3.2. Eﬀect of Zingiber oﬃcinale on Event-Related Potential
Components (ERPs). The grand average mean for all three
conditions is shown in Table 2 and the average waveforms
are shown in Figure 1. The predose baseline data of latency
and amplitude for both the N100 and P300 of each group
showed no signiﬁcant diﬀerence (F(2,57) = 0.3765, P =
0.6879; F(2,57) = 0.1865, P = 0.8303; F(2,57) = 0.0408,
P = 0.9600 and F(2,57) = 0.0138, P = 0.9863, resp.). After
one month of treatment, the subjects who received Zingiber
oﬃcinale at a dose of 800mg showed a signiﬁcant increase
in N100 amplitude (t = 3.3076, P = 0.0010). After two
months, participants who were given Zingiber oﬃcinale at
doses of 400 and 800mg showed a signiﬁcant increase in
P300 amplitude (t = 2.4551, P = 0.0094 and t = 3.0716, P =
0.0020, resp.). Furthermore, subjects who received Zinigber
oﬃcinale at a dose of 800mg showed a signiﬁcant increase
in N100 amplitude and decreased P300 latency (t = 3.1847,
P = 0.0014 and t = 3.6561, P = 0.0004, resp.).
3.3. Eﬀect of Zingiber oﬃcinale on Working Memory. Prior to
the determination of Zingiber oﬃcinale on working memory,
baseline data and mean predose raw baseline scores for
all three conditions (placebo, 400, and 800mg Zingiber
oﬃcinale) for each individual task scores were subjected to a
one-way ANOVA. No signiﬁcant changes in any parameters
were observed.Evidence-Based Complementary and Alternative Medicine 5
Table 2: Eﬀect of Zingiber oﬃcinale on auditory event-related potential.
Wave
Predose baseline score Postdose score
1 month 2 months
N100
latency
Placebo 116.80 ±1.385 114.50 ±11.97 113.85 ±10.24
400mg 114.35 ±11.44 113.25 ±11.85 110.35 ±10.17
800mg 114.05 ±8.31 109.95 ±8.72 106.75 ±9.13
N100
amplitude
Placebo 5.70 ±10.08 5.65 ± 1.08 5.70 ±1.07
400mg 5.90 ±1.37 6.40 ± 1.18 6.55 ±1.05
800mg 5.75 ±1.29 7.05 ±1.19∗∗ 6.90 ±0.96∗∗∗
P300
latency
Placebo 332.70 ±12.96 330.30 ±11.02 332.35 ±8.99
400mg 332.25 ±13.81 329.45 ±11.78 323.85 ±13.10
800mg 332.90 + 10.20 325.60 ±12.91 321.35 ±9.77∗∗∗
P300
amplitude
Placebo 7.25 ±1.10 7.25 ± 1.06 7.20 ±1.05
400mg 7.25 ±1.01 7.50 ± 1.23 8.10 ±1.16∗∗
800mg 7.20 ±1.10 7.90 ±1.02 8.40 ±1.35∗∗
The amplitudes and latencies of event-related potential elicited by oddball paradigm at Cz electrode were measured. Data are presented as mean ±SD (n =
20/group).
∗∗, ∗∗∗P value < 0.05, 0.01, and 0.001 compared to placebo-treated group, respectively.
The mean raw baseline scores and changes from baseline
factor scores for each condition across each session are
presented in Table 3. It was found that participants who
consumed Zingiber oﬃcinale at the dose of 800mg/day for
one month showed a signiﬁcant increase in % accuracy of
choice reaction time and numeric working memory (t =
4.1014, P = 0.0001, t = 1.9467, P = 0.0295, resp.). At
two months of intervention, subjects who received Zingiber
oﬃcinale at the dose of 400mg/day showed a signiﬁcantly
decreased reaction time for word recognition (msec.) (t =
2.4000, P = 0.0107) while subjects who received Zingiber
oﬃcinale at the dose of 800mg/day showed signiﬁcant
changes in % accuracy of delayed word recognition, digit
vigilance, choice reaction, numeric working memory and
spatialworkingmemory(t = 2.8799,P = 0.0033;t = 2.0904,
P = 0.0217; t = 4.2279, P<0.0001; t = 2.9313, P = 0.0028
and t = 3.0325, P = 0.0022, resp.). In addition, signiﬁcant
diﬀerences in numerous parameters including reaction time
of the following: word recognition (t = 2.8204, P = 0.0037)
and choice reaction time (t = 2.1778, P = 0.0178) were
alsoobservedinsubjectswhoconsumedZingiberoﬃcinaleat
the dose of 800mg/day. Therefore, the current data suggests
that the plant extract at doses used in this study especially
Zingiber oﬃcinale at the dose of 800mg/day could improve
working memory in all domains including (1) power of
attention (obtained from reaction times of simple reaction
time, choice reaction time, and digit vigilance tests), (2) the
continuity of attention or accuracy of attention (indicated
by the elevation of % accuracy of the parameters mentioned
above), (3) the speed of memory (indicated by the reaction
time of simple reaction, digit vigilance, choice reaction,
numeric working memory, picture recognition, and spatial
working memory), and (4) quality of memory (indicated
by the % accuracy of the parameters mentioned in 3).
All participants completed the trial for the whole period.
Moreover, no adverse eﬀects after substance administration
were observed.
4. Discussion
The present study clearly demonstrates that Zingiber oﬃci-
nale may enhance both the attention and cognitive process-
ing in middle-aged women. Our event-related potential and
computerized battery test (for assessing working memory)
data showed that the improvement of cognitive function was
observed in all attention and cognitive processing domains.
During the last decade, numerous lines of evidence point out
that event-related potential (ERP) components are sensitive
to the attention and working memory demand of a task
[14, 15]. Previous studies show that stimuli that require
active discrimination between classes of events typically
evoke a large positive voltage deﬂection in the interval
between 300 to 500ms following the stimulus onset, which
is known as P3 or P300 [16]. This component corresponds
to mental processes such as recognition, categorization of
stimuli, expectancy, or short-term memory. The amplitude
of this wave is correlated with individual diﬀerences in
working memory capacity [17]. P300 latency is regarded as
a measurement of relative timing of the stimulus valuation
process, indicating stimulus evaluating time [18]. Numerous
brain regions including the temporal lobe, parietal lobe,
and hippocampus have been proposed to be involved in its
generation [19]. Recent ﬁndings show that the N100 reﬂects
the process of attention activation, analysis of information
based on the physical characteristics of sound, and the
formation of memory trace with oscillators in the auditory
cortex, prefrontal cortex, hippocampus, and cingulate cortex
[20]. Moreover, the amplitude of N100 was also reported
to be associated with enhanced memory performance [21],
attention [22], expectancy [23], and tasks involving short-
term memory [24].6 Evidence-Based Complementary and Alternative Medicine
Table 3: Eﬀect of Zingiber oﬃcinale on working memory assessing via computerized battery test.
Measurement
Predose baseline score Post-dose score
1 month 2 months
(1) Delay word recognition (% accuracy)
Placebo 72.99 ±8.97 73.88 ±9.25 75.33 ±8.94
400mg 74.83 ±8.27 75.83 ±8.58 80.17 ±7.45
800mg 74.83 ±13.39 79.00 ±12.14 84.89 ±8.03∗∗
(2) Delay word recognition reaction time
(msec.)
Placebo 1242.56 ±217.14 1247.75 ±256.32 1245.06 ±165.89
400mg 1226.06 ±161.82 1221.45 ±176.35 1120.67 ±111.2∗
800mg 1261.14 ±176.75 1109.55 ±171.69 1099.67 ±185.22∗∗
(3) Simple reaction time (msec.)
Placebo 619.05 ±222.35 622.50 ±175.01 625.15 ±161.96
400mg 616.25 ±195.39 611.95 ±185.75 596.30 ±126.60
800mg 623.25 ±191.43 614.30 ±175.48 573.95 ±177.20
(4) Digit vigilance (% accuracy)
Placebo 43.35 ±6.84 42.90 ±7.95 42.45 ±8.744
400mg 42.90 ±5.05 43.45 ±9.93 43.70 ±6.52
800mg 44.75 ±5.63 44.65 ±6.45 48.40 ±5.40∗
(5) Digit Vigilance reaction time (msec.)
Placebo 631.65 ±140.92 622.25 ±109.91 626.60 ±122.24
400mg 620.00 ±122.74 621.80 ±105.69 594.70 ±83.15
800mg 623.75 ±109.55 608.70 ±130.34 587.40 ±71.65
(6) Digit vigilance false alar number
Placebo 8.85 ±2.39 8.7 ±1.55 8.5 ±1.35
400mg 8.85 ±2.18 8.25 ±1.61 8.05 ±1.43
800mg 8.65 ±2.13 7.35 ±1.34 7.1 ±1.44∗∗
(7) Choice reaction time (% accuracy)
Placebo 79.90 ±7.40 81.70 ±6.68 80.55 ±7.47
400mg 80.00 ±8.86 84.95 ±9.23 85.40 ±7.92
800mg 79.05 ±8.53 89.95 ±8.26∗∗ 90.00 ±7.82∗∗∗
(8) Choice reaction time response (msec.)
Placebo 976.00 ±168.70 964.25 ±100.98 961.30 ±135.76
400mg 964.55 ±191.10 944.80 ±128.93 912.10 ±71.58
800mg 980.35 ±197.24 915.90 ±72.00 874.65 ±50.59∗
(9) Numeric working memory (% accuracy)
Placebo 73.90 ±10.40 75.00 ±10.43 74.70 ±10.54
400mg 75.50 ±8.67 77.10 ±10.95 81.35 ±9.57∗
800mg 76.45 ±9.69 82.40 ±9.63∗ 85.00 ±8.72∗∗
(10) Numeric working memory reaction
time (msec.)
Placebo 1334.50 ±226.25 1348.29 ±209.25 1335.70 ±203.13
400mg 1339.40 ±234.61 1343.90 ±236.38 1325.05 ±171.35
800mg 1335.60 ±260.95 1337.10 ±170.24 1313.95 ±138.71
(11) Picture recognition (% accuracy)
Placebo 72.99 ±8.97 73.88 ±9.25 75.33 ±8.94
400mg 74.83 ±8.27 75.83 ±8.58 80.17 ±7.45
800mg 74.83 ±13.39 79.00 ±12.14 84.89 ±8.03
(12) Picture recognition reaction time
(msec.)
Placebo 1256.88 ±239.51 1247.75 ±156.32 1245.06 ±165.89
400mg 1224.88 ±185.08 1221.45 ±176.35 1120.67 ±111.25
800mg 1234.61 ±197.52 1109.55 ±171.96 1099.67 ±185.22
(13) Spatial working memory (% accuracy)
Placebo 66.25 ±6.64 66.13 ±5.39 66.29 ±4.59
400mg 66.11 ±5.47 66.95 ±5.47 70.53 ±5.34∗∗
800mg 66.33 ±6.88 68.39 ±7.08 71.77 ±4.12∗∗
(14) Spatial working memory reaction time
(msec.)
Placebo 1799.25 ±33.45 1817.30 ±203.17 1844.10 ±232.15
400mg 1784.30 ±191.92 1707.85 ±296.62 1761.55 ±165.96
800mg 1712.75 ±219.45 1695.75 ±200.13 1704.40 ±309.16
Subjects were measured for power of attention, continuity of attention, speed of memory, and quality of memory by using computerized battery test. Data are
presented as mean ± SD (n = 20/group).
∗, ∗∗, ∗∗∗P value < 0.05, 0.01, and 0.001 compared to placebo-treated group, respectively.Evidence-Based Complementary and Alternative Medicine 7
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Figure 2: Eﬀect of Zingiber oﬃcinale on attention, cognitive processing capabilities, and working memory of healthy, middle-aged women.
Several studies have also suggested that the high power
of attention represents the intensity of concentration at
a particular moment, with faster responses reﬂecting a
higher focus of attention. It has been reported that the
power of attention can be evaluated in choice reaction time
and digit vigilance tests while the continuity of attention
is also able to be evaluated using the % accuracy tests
mentioned earlier. In addition, the speed and quality of
memory are also evaluated by using the reaction time and %
accuracy of numeric working memory, spatial memory, and
word/picture recognition [25].
With regard to the assessment of working memory
via the computerized battery test in accompany with the
assessment of brain activity during cognitive performance,
our results show that Zingiber oﬃcinale could enhance
both attention and the eﬃciency of cognitive processing.
However, the alteration in attention appears to be more
sensitive to the eﬀect of the plant extract rather than
the cognitive processing. Previous studies report that the
lateral prefrontal cortex (PFC) plays an important role in
executive function such as planning, regulating behavior,
and ﬁnding solutions to novel problems. Moreover, this
area also contributes to the signiﬁcant role of numeric
working memory and is also critical for picture and word
recognition process [26, 27]. Recent ﬁndings also suggest
an important role of the hippocampus in spatial working
memory [28]. In addition, it was found that dopamine,
and norepinephrine play a key role in numeric working
memory including word and picture recognition (organized
by the lateral PFC), while acetylcholine and serotonin in the
hippocampus simultaneously were activated during spatial
working memory tasks [29].
Zingiber oﬃcinale was previously reported to enhance
the level of norepinephrine, epinephrine, dopamine and
serotonin contents in the cerebral cortex and hippocampus
[30]. Moreover, this plant extract and its active component,
6-gingerol, also inhibited the cholinesterase activity which
in turn increased acetylcholine (ACh), a neurotransmitter
that plays an important role in learning and memory [31].
A recent study demonstrated that ginger extract enhanced
the memory performance induced by cerebral ischemia by
decreasing infarct volume in both cortical and subcortical
areas [6]. Therefore, taking all data together, we suggest that
the cognitive enhancing eﬀects of Zingiber oﬃcinale might
be partly associated with the modulation eﬀect of this plant
extract on the alteration of both the monoamine system and
the cholinergic system in various brain areas, including the
prefrontal cortex and hippocampus.
Recent accumulating lines of evidence show that antiox-
idants could also improve cognitive performance in healthy
elderly subjects [32, 33]; therefore, the association between
the antioxidant eﬀects of Zingiber oﬃcinale and the cognitive
enhancing eﬀects still cannot be excluded [6, 34].
According to the cognitive enhancing eﬀects of sub-
stances possessing antioxidant activity, the concentration of
gingerol and shogaol of the extract, and the antioxidant
activity of Zingiber oﬃcinale, we suggest that the cognitive
enhancing eﬀect of this plant extract on working memory
observed in this study might be partly related to its antiox-
idant eﬀect. However, the precise underlying mechanism
and possible active ingredient responsible for the cognitive
enhancing eﬀect of Zingiber oﬃcinale still require further
investigation.
Although the side eﬀect of Z. oﬃcinale extract is rare
which is corresponding with our data [35–37], some minor
adverse eﬀects at higher doses such as gastrointestinal distur-
bance, sleepiness, restlessness, sedation, and heartburn were
also reported [38–40]. Moreover, the extract could therefore
also possibly interact with medications including anesthesia,
anticoagulants, and analgesics leading to arrhythmias, poor
wound healing, bleeding, photosensitivity reaction, and
prolongedsedation[41,42].Therefore,theapplicationinthe
mentioned conditions should be performed with caution.
5. Conclusion
The present study demonstrates that ginger extract enhances
both attention and cognitive processing capabilities of8 Evidence-Based Complementary and Alternative Medicine
healthy, middle-aged women, with no side eﬀects reported.
Therefore, our data reveal that Zingiber oﬃcinale extract is
a potential brain tonic to enhance cognitive function for
middle-age women (Figure 2). However, further study about
the precise underlying mechanism especially the eﬀect of the
extract on the alteration of acetylcholine and monoamine
transmitters should be performed.
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